SEARCH RESULTS FOR:

PRESIDENT & CEO, OUTLOOK THERAPEUTICS

United States Life Sciences 2022

"If our ophthalmic bevacizumab is approved, we will potentially enhance the standard of care for patients with disorders like wet AMD, diabetic macular edema, and branch retinal vein occlusion by removing concerns related to off-label repackaged IV product."

United States

Pharma & Life Sciences

Albert Friesen

CEO & CHAIRMAN OF THE BOARD, MEDICURE INC.

United States Life Sciences 2022

"Our recently launched e-commerce site for Marley Drug has huge potential and will be our most significant driver of growth and major source of our profits moving forward."

Mining

Peru

SPANISH

Guillermo Barreda

GERENTE GENERAL, KNIGHT PIÉSOLD PERÚ

Knight Piésold elaborates on the company’s experience in engineering and environmental services. (Spanish interview)

Mexico

Petrochemicals & Chemicals

Arturo Molina

MANAGING DIRECTOR – MEXICO, COVESTRO

Covestro Mexico explains its initiatives towards a circular economy.

Petrochemicals & Chemicals

Singapore

Gina Fyffe

CEO, INTEGRA PETROCHEMICALS

Singapore Chemicals 2021

Integra Petrochemicals in Singapore describes how it manages the challenges of today’s confusing market place.

United States

Pharma & Life Sciences

Patricio Massera

CEO, AGC BIOLOGICS

AGC Biologic’s explains its expansion in the US.

United States

Pharma & Life Sciences

Olga Potapova

FOUNDER, CEO & SCIENTIFIC DIRECTOR, CURELINE

Cureline updates GBR on its global activities.

United States

Pharma & Life Sciences

Jennifer Cannon

SVP GLOBAL HEAD OF MAMMALIAN BIOLOGICS, LONZA

"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."

United States

Pharma & Life Sciences

Mark Egerton

CEO, QUOTIENT SCIENCES

"The focus of our integrated Translational Pharmaceutics programs is to provide the customer with a development platform capable of responding in real-time to emerging development data and maintain an overall timeline to proof of concept."